Pfizer: Meningitis, Cryptococcal trials
The registry lists 11 Meningitis, Cryptococcal studies with Pfizer as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 3 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin BCompletedNCT00002306Not applicable
- A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal MeningitisCompletedNCT00002305Not applicable
- A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDSCompletedNCT00002294Not applicable
- A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.CompletedNCT00002113Not applicable
- An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00002077Not applicable
- Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00002076Not applicable
- Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisCompletedNCT00002075Not applicable
- Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency SyndromeCompletedNCT00002074Not applicable
- A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal MeningitisCompletedNCT00002068Not applicable
- Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal MeningitisCompletedNCT00002040Not applicable
- Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDSCompletedNCT00001017Phase 3